-
-
-
Comparative effectiveness of omalizumab, mepolizumab, and dupilumab in asthma: A target trial emulation. J Allergy Clin Immunol. 2023 Feb 3:S0091-6749(23)00144-6.
- 2023.04.24 ｜ 抄読会論文
- 抄読会要旨 穴井盛靖...
-
-
-
-
Dupilumab increases aspirin tolerance in NSAID exacerbated respiratory disease (N-ERD) Schneider S, et.al: Eur Respir J. 2022;in press
- 2023.04.21 ｜ 抄読会論文
- 抄読会要旨 吉田知栄子...
-
-
-
-
2023年度実績
- 2023.04.14 ｜ 研究実績
- 2023年度業績 【英文論文】 Fukuko Horio, Tokunori Ik...
-
-
-
-
2022年度実績
- 2023.04.14 ｜ 研究実績
- 2022年度業績 【英文論文】 Imaji M, Fujimoto D, Sato...
-
-
-
-
B cell-activating factors in autoimmune pulmonary alveolar proteinosis Journal：Orphanet Journal of Rare Disease
- 2023.03.29 ｜ 抄読会論文
- 抄読会要旨 木村俊貴...
-
-
-
-
Lung transplantation for acute exacerbation of interstitial lung disease Mwelwa Chizinga, Tiago N Machuca, Abbas Shahmohammadi, Divya C Patel, Ayoub Innabi, Bashar Alzghoul, Vanessa Scheuble, Mauricio Pipkin, Borna Mehrad , Andres Pelaez, Christine Lin, Diana Gomez- Manjarres
- 2023.01.31 ｜ 抄読会論文
- 抄読会要旨 増永愛子...
-
-
-
-
Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomized, controlled, phase 2b trial.
- 2023.01.26 ｜ 抄読会論文
- 抄読会要旨 岡林比呂子...
-
-
-
-
Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non–Small-Cell Lung Cancer: The Phase III POSEIDON Study
- 2023.01.16 ｜ 抄読会論文
- 抄読会要旨 猿渡功一...
-
-
-
-
Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer
- 2023.01.5 ｜ 抄読会論文
- 抄読会要旨 冨田 雄介...
-
-
-
-
High-flow nasal cannula versus conventional oxygen therapy in acute COPD exacerbation with mild hypercapnia: a multicenter randomized controlled trial
- 2022.11.21 ｜ 抄読会論文
- 抄読会要旨 髙木僚...
-
